Celltrion eyes new production plant, aims for W5tr in sales
IndustrySept 9, 2024
Celltrion Group Founder and Chairman Seo Jung-jin has announced plans to expand the company's pharmaceutical production facilities either in South Korea or abroad as part of its strategy to enter the contract development and manufacturing organization sector. The biosimilar giant also aims to commercialize a total of six new drug pipelines by the end of 2029. "Expanding manufacturing facilities is crucial for securing production capacity and ensuring a sustainable future," Seo rep